FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation.
Fay
J W
JW
Baylor University Medical Center, Dallas, Texas.
Nash
R A
RA
Wingard
J R
JR
Przepiorka
D
D
Collins
R H
RH
Anasetti
C
C
Devine
S M
SM
Piñeiro
L A
LA
Storb
R F
RF
Aro
R M
RM
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D005260:Female; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D015994:Incidence; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010865:Pilot Projects; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D014019:Tissue Donors
D016559:Tacrolimus; D008775:Methylprednisolone; D008727:Methotrexate